January 25, 2013

Gleevec's latest approval is for pediatric cancer

(HealthDay)—The anti-cancer drug Gleevec (imatinib) has received new U.S. Food and Drug Administration approval to treat the most common type of pediatric cancer, affecting some 2,900 children each year, the agency said Friday.

Philadelphia chromosome positive (ALL) progresses rapidly if left untreated. Gleevec, among a class of drugs called , blocks proteins that promote development of cancer cells, the FDA said in a news release.

The most common side effects observed in pediatric testing included infection and a decrease in white blood cells and blood platelets.

Gleevec was first approved in 2001 to treat a form of , and has since been approved to treat several other conditions. The drug is marketed by Novartis, based in East Hanover, N.J.

More information: To learn more about Gleevec, visit the U.S. National Cancer Institute.

Health News Copyright © 2013 HealthDay. All rights reserved.

Citation: Gleevec's latest approval is for pediatric cancer (2013, January 25) retrieved 25 April 2024 from https://medicalxpress.com/news/2013-01-gleevec-latest-pediatric-cancer.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Iclusig approved for rare leukemias
 shares

Feedback to editors
Cancer drug trial provides lessons for future

36 minutes ago
Treatment for deadly superbug C. diff may be weakening

42 minutes ago
Blocking gene may halt growth of breast cancer cells

56 minutes ago
Study finds RNA modification is responsible for disruption of mitochondrial protein synthesis in Alzheimer's disease

1 hour ago
Nanomaterial that mimics proteins could be basis for new neurodegenerative disease treatments

1 hour ago
How immune cells communicate to fight viruses: New mouse model enables identification of chemokine producers and sensors

2 hours ago
Differentiating cerebral cortical neurons to decipher molecular mechanisms of neurodegeneration

2 hours ago
National trial safely scales back prescribing of a powerful antipsychotic for the elderly

2 hours ago
With hybrid brains, these mice smell like a rat

2 hours ago
Premature mortality higher among sexual minority women, study finds

2 hours ago
Load comments (0)